tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Argenx Se (ARGX) and Tecan Group AG (OtherTCHBF)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGENResearch Report), Argenx Se (ARGXResearch Report) and Tecan Group AG (TCHBFResearch Report).

Qiagen (QGEN)

In a report issued on January 20, Oliver Reinberg from Kepler Capital maintained a Hold rating on Qiagen, with a price target of EUR50.00. The company’s shares closed last Friday at $48.69.

According to TipRanks.com, Reinberg has 0 stars on 0-5 stars ranking scale with an average return of -2.9% and a 47.1% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, Koninklijke Philips, and Tecan Group AG.

Currently, the analyst consensus on Qiagen is a Moderate Buy with an average price target of $56.85.

See Insiders’ Hot Stocks on TipRanks >>

Argenx Se (ARGX)

In a report issued on January 20, Daan Vandenberk from Kepler Capital maintained a Buy rating on Argenx Se, with a price target of EUR300.00. The company’s shares closed last Friday at $279.25.

According to TipRanks.com, Vandenberk is ranked #7137 out of 7764 analysts.

Currently, the analyst consensus on Argenx Se is a Strong Buy with an average price target of $377.81, which is a 34.5% upside from current levels. In a report issued on January 7, Piper Sandler also maintained a Buy rating on the stock with a $375.00 price target.

Tecan Group AG (TCHBF)

Kepler Capital analyst Jon Berggren maintained a Buy rating on Tecan Group AG on January 20 and set a price target of CHF640.00. The company’s shares closed last Monday at $488.00.

According to TipRanks.com, Berggren is ranked #5538 out of 7764 analysts.

Currently, the analyst consensus on Tecan Group AG is a Strong Buy with an average price target of $672.73.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on QGEN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed